The Veteran's claims for service connection for various conditions, including diabetes mellitus and its related complications, prostate disability/benign prostatic hypertrophy (BPH), adrenal gland tumor, and peripheral neuropathy of the upper and lower extremities have been denied as there is no evidence to support a direct relationship between these conditions and his military service.
The deciding factor: The Veteran did not serve in Vietnam and was not exposed to Agent Orange. The preponderance of evidence does not support a connection between any of the claimed disabilities and his military service.
- Claimed conditions
- Type 2 Diabetes Mellitus
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- September 24, 2018
- Citation
- 18137829
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 18137829.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied service connection for a right hip disability and type 2 diabetes mellitus, finding that the evidence did not support an in-service disease or injury related to these conditions.,Both the right hip disability and type 2 diabetes mellitus were found to have no onset during service or within one year of separation from service.
- Denied
The Board denied the claims for increased ratings for diabetes mellitus, hypertension, and hypothyroidism, as well as remanded the claims for service connection of left and right hip disabilities.
- Remanded (sent back)
The Board has remanded the claims for service connection for type 2 diabetes mellitus and peripheral neuropathy of the bilateral lower extremity due to potential association with in-service symptoms.
- Denied
The Board has denied the appeal challenging the reduction of the Veteran's type 2 diabetes mellitus rating from 60 percent to 20 percent, effective May 1, 2023. The evidence shows improvement in ability to function under ordinary conditions of life and work.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.